Alkermes plc (NASDAQ: ALKS) kicked off on Monday, down -1.98% from the previous trading day, before settling in for the closing price of $28.27. Over the past 52 weeks, ALKS has traded in a range of $20.46-$32.88.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 10.61%. While this was happening, its average annual earnings per share was recorded 84.32%. With a float of $161.57 million, this company’s outstanding shares have now reached $166.98 million.
Let’s determine the extent of company efficiency that accounts for 2100 employees. In terms of profitability, gross margin is 82.45%, operating margin of 16.69%, and the pretax margin is 17.86%.
Alkermes plc (ALKS) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Alkermes plc is 1.88%, while institutional ownership is 109.34%. The most recent insider transaction that took place on Mar 18 ’24, was worth 292,740. In this transaction SVP, Chief Commercial Officer of this company sold 10,417 shares at a rate of $28.10, taking the stock ownership to the 65,911 shares. Before that another transaction happened on Feb 27 ’24, when Company’s VP, Finance (Interim PAO) sold 2,559 for $29.65, making the entire transaction worth $75,874. This insider now owns 7,717 shares in total.
Alkermes plc (ALKS) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 6/30/2024, the organization reported 0.64 earnings per share (EPS), higher than consensus estimate (set at 0.44) by 0.2. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.79 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 84.32% per share during the next fiscal year.
Alkermes plc (NASDAQ: ALKS) Trading Performance Indicators
Take a look at Alkermes plc’s (ALKS) current performance indicators. Last quarter, stock had a quick ratio of 2.61. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.03. Likewise, its price to free cash flow for the trailing twelve months is 13.95.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.69, a number that is poised to hit 0.72 in the next quarter and is forecasted to reach 2.57 in one year’s time.
Technical Analysis of Alkermes plc (ALKS)
Looking closely at Alkermes plc (NASDAQ: ALKS), its last 5-days average volume was 1.27 million, which is a drop from its year-to-date volume of 1.82 million. As of the previous 9 days, the stock’s Stochastic %D was 60.45%. Additionally, its Average True Range was 0.88.
During the past 100 days, Alkermes plc’s (ALKS) raw stochastic average was set at 73.32%, which indicates a significant increase from 48.98% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 40.79% in the past 14 days, which was higher than the 32.90% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $27.74, while its 200-day Moving Average is $26.60. However, in the short run, Alkermes plc’s stock first resistance to watch stands at $28.21. Second resistance stands at $28.71. The third major resistance level sits at $29.10. If the price goes on to break the first support level at $27.32, it is likely to go to the next support level at $26.93. Should the price break the second support level, the third support level stands at $26.43.
Alkermes plc (NASDAQ: ALKS) Key Stats
The company with the Market Capitalisation of 4.56 billion has total of 169,221K Shares Outstanding. Its annual sales at the moment are 1,663 M in contrast with the sum of 355,760 K annual income. Company’s last quarter sales were recorded 399,130 K and last quarter income was 91,360 K.
